Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Liposomal Doxorubicin and Docetaxel in HER2 Negative Metastatic Breast Cancer (MYOTAX)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00377559
Recruitment Status : Completed
First Posted : September 18, 2006
Last Update Posted : October 6, 2015
Sponsor:
Collaborators:
Cephalon
Sanofi
Information provided by:
Catharina Ziekenhuis Eindhoven

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 2009
Actual Study Completion Date : July 2011